INTERSECT ENT INC's ticker is XENT and the CUSIP is 46071F103. A total of 50 filers reported holding INTERSECT ENT INC in Q3 2014. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $1,389,000 | -47.4% | 49,605 | -48.7% | 0.00% | -50.0% |
| Q4 2021 | $2,643,000 | -43.0% | 96,764 | -43.2% | 0.00% | -50.0% |
| Q3 2021 | $4,638,000 | -15.5% | 170,504 | -46.9% | 0.00% | -20.0% |
| Q2 2021 | $5,492,000 | -24.9% | 321,374 | -8.2% | 0.01% | -28.6% |
| Q1 2021 | $7,311,000 | -28.4% | 350,140 | -21.5% | 0.01% | -22.2% |
| Q4 2020 | $10,212,000 | +31.3% | 445,933 | -6.5% | 0.01% | +12.5% |
| Q3 2020 | $7,776,000 | -2.4% | 476,777 | -19.0% | 0.01% | -11.1% |
| Q2 2020 | $7,966,000 | +289.5% | 588,330 | +240.9% | 0.01% | +200.0% |
| Q1 2020 | $2,045,000 | -82.2% | 172,569 | -62.5% | 0.00% | -76.9% |
| Q4 2019 | $11,458,000 | +182.8% | 460,132 | +93.2% | 0.01% | +160.0% |
| Q3 2019 | $4,052,000 | +28.4% | 238,215 | +71.9% | 0.01% | +25.0% |
| Q2 2019 | $3,155,000 | -49.6% | 138,609 | -28.8% | 0.00% | -50.0% |
| Q1 2019 | $6,260,000 | +70.6% | 194,699 | +49.5% | 0.01% | +60.0% |
| Q4 2018 | $3,670,000 | +11.3% | 130,226 | +13.5% | 0.01% | +25.0% |
| Q3 2018 | $3,298,000 | +6.3% | 114,711 | +38.5% | 0.00% | 0.0% |
| Q2 2018 | $3,102,000 | +162.7% | 82,823 | +175.5% | 0.00% | +100.0% |
| Q1 2018 | $1,181,000 | -61.0% | 30,060 | -67.9% | 0.00% | -50.0% |
| Q4 2017 | $3,030,000 | -29.3% | 93,511 | -32.0% | 0.00% | -42.9% |
| Q3 2017 | $4,283,000 | +22.4% | 137,480 | +9.8% | 0.01% | +16.7% |
| Q2 2017 | $3,500,000 | +404.3% | 125,237 | +209.4% | 0.01% | +500.0% |
| Q1 2017 | $694,000 | +74.8% | 40,480 | +23.4% | 0.00% | 0.0% |
| Q4 2016 | $397,000 | -47.6% | 32,817 | -31.3% | 0.00% | 0.0% |
| Q3 2016 | $757,000 | +90.7% | 47,760 | +128.6% | 0.00% | 0.0% |
| Q1 2016 | $397,000 | -86.4% | 20,894 | -83.9% | 0.00% | -75.0% |
| Q4 2015 | $2,920,000 | -32.1% | 129,787 | -29.4% | 0.00% | -33.3% |
| Q3 2015 | $4,300,000 | +14.0% | 183,742 | +39.4% | 0.01% | 0.0% |
| Q2 2015 | $3,773,000 | +177.2% | 131,802 | +150.2% | 0.01% | +200.0% |
| Q1 2015 | $1,361,000 | +140.5% | 52,674 | +72.6% | 0.00% | +100.0% |
| Q4 2014 | $566,000 | +25.5% | 30,512 | +4.9% | 0.00% | 0.0% |
| Q3 2014 | $451,000 | – | 29,086 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KOPP INVESTMENT ADVISORS LLC | 186,561 | $5,364,000 | 4.51% |
| First Light Asset Management, LLC | 517,121 | $14,867,000 | 2.40% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,147,950 | $61,754,000 | 2.21% |
| HealthCor Management, L.P. | 1,950,000 | $56,063,000 | 1.86% |
| PURA VIDA INVESTMENTS, LLC | 200,000 | $5,750,000 | 1.21% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 112,000 | $2,469,000 | 1.17% |
| Broadfin Capital, LLC | 234,200 | $6,733,000 | 0.99% |
| Lombard Odier Asset Management (USA) Corp | 240,000 | $6,900,000 | 0.51% |
| PURA VIDA INVESTMENTS, LLC | 83,527 | $2,401,000 | 0.50% |
| Rock Springs Capital Management LP | 460,000 | $13,225,000 | 0.48% |